143 related articles for article (PubMed ID: 30378045)
1. Pancreatic Microtumors: A Novel 3D Ex Vivo Testing Platform.
Goodwin ML; Urs SK; Simeone DM
Methods Mol Biol; 2019; 1882():73-80. PubMed ID: 30378045
[TBL] [Abstract][Full Text] [Related]
2. Cellular context-dependent interaction between cancer and stellate cells in hetero-type multicellular spheroids of pancreatic tumor.
Nam S; Khawar IA; Park JK; Chang S; Kuh HJ
Biochem Biophys Res Commun; 2019 Jul; 515(1):183-189. PubMed ID: 31133378
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-induced Cavitation enhances the efficacy of Chemotherapy in a 3D Model of Pancreatic Ductal Adenocarcinoma with its microenvironment.
Leenhardt R; Camus M; Mestas JL; Jeljeli M; Abou Ali E; Chouzenoux S; Bordacahar B; Nicco C; Batteux F; Lafon C; Prat F
Sci Rep; 2019 Dec; 9(1):18916. PubMed ID: 31831785
[TBL] [Abstract][Full Text] [Related]
4. Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer.
Zhang L; Yao J; Li W; Zhang C
Oncol Res; 2018 Jul; 26(6):827-835. PubMed ID: 28477403
[TBL] [Abstract][Full Text] [Related]
5. A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay.
Wen Z; Liao Q; Hu Y; You L; Zhou L; Zhao Y
Braz J Med Biol Res; 2013 Jul; 46(7):634-42. PubMed ID: 23903680
[TBL] [Abstract][Full Text] [Related]
6. Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer.
Takahashi R; Ijichi H; Sano M; Miyabayashi K; Mohri D; Kim J; Kimura G; Nakatsuka T; Fujiwara H; Yamamoto K; Kudo Y; Tanaka Y; Tateishi K; Nakai Y; Morishita Y; Soma K; Takeda N; Moses HL; Isayama H; Koike K
Sci Rep; 2020 Dec; 10(1):21194. PubMed ID: 33273652
[TBL] [Abstract][Full Text] [Related]
7. Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.
Weizman N; Krelin Y; Shabtay-Orbach A; Amit M; Binenbaum Y; Wong RJ; Gil Z
Oncogene; 2014 Jul; 33(29):3812-9. PubMed ID: 23995783
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.
Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
Cancer Lett; 2017 Jan; 385():65-74. PubMed ID: 27840243
[TBL] [Abstract][Full Text] [Related]
9. Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D.
Laurent J; Frongia C; Cazales M; Mondesert O; Ducommun B; Lobjois V
BMC Cancer; 2013 Feb; 13():73. PubMed ID: 23394599
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Invasive Activity of CAF Spheroids into Three Dimensional (3D) Collagen Matrices.
Villaronga MÁ; Teijeiro SÁ; Hermida-Prado F; Garzón-Arango M; Sanz-Moreno V; García-Pedrero JM
Methods Mol Biol; 2018; 1731():145-154. PubMed ID: 29318551
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer.
Wei L; Ye H; Li G; Lu Y; Zhou Q; Zheng S; Lin Q; Liu Y; Li Z; Chen R
Cell Death Dis; 2018 Oct; 9(11):1065. PubMed ID: 30337520
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer.
Fang Y; Zhou W; Rong Y; Kuang T; Xu X; Wu W; Wang D; Lou W
Exp Cell Res; 2019 Oct; 383(1):111543. PubMed ID: 31374207
[TBL] [Abstract][Full Text] [Related]
13. Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer.
Lee J; Yakubov B; Ivan C; Jones DR; Caperell-Grant A; Fishel M; Cardenas H; Matei D
Neoplasia; 2016 Nov; 18(11):689-698. PubMed ID: 27792935
[TBL] [Abstract][Full Text] [Related]
14. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
Meier-Hubberten JC; Sanderson MP
Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model.
Kuen J; Darowski D; Kluge T; Majety M
PLoS One; 2017; 12(7):e0182039. PubMed ID: 28750018
[TBL] [Abstract][Full Text] [Related]
16. TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.
Hesler RA; Huang JJ; Starr MD; Treboschi VM; Bernanke AG; Nixon AB; McCall SJ; White RR; Blobe GC
Carcinogenesis; 2016 Nov; 37(11):1041-1051. PubMed ID: 27604902
[TBL] [Abstract][Full Text] [Related]
17. Mimicking the tumor microenvironment to regulate macrophage phenotype and assessing chemotherapeutic efficacy in embedded cancer cell/macrophage spheroid models.
Tevis KM; Cecchi RJ; Colson YL; Grinstaff MW
Acta Biomater; 2017 Mar; 50():271-279. PubMed ID: 28011141
[TBL] [Abstract][Full Text] [Related]
18. Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer.
Neumann CCM; von Hörschelmann E; Reutzel-Selke A; Seidel E; Sauer IM; Pratschke J; Bahra M; Schmuck RB
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):461-472. PubMed ID: 30243879
[TBL] [Abstract][Full Text] [Related]
19. Stratified 3D Microtumors as Organotypic Testing Platforms for Screening Pancreatic Cancer Therapies.
Monteiro MV; Gaspar VM; Mendes L; Duarte IF; Mano JF
Small Methods; 2021 May; 5(5):e2001207. PubMed ID: 34928079
[TBL] [Abstract][Full Text] [Related]
20. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer.
Liu Y; Li F; Gao F; Xing L; Qin P; Liang X; Zhang J; Qiao X; Lin L; Zhao Q; Du L
Tumour Biol; 2016 Nov; 37(11):15283-15291. PubMed ID: 27696296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]